Navigation Links
NYU Langone experts find MRI techniques can detect early osteoarthritis

Researchers from NYU Langone Medical Center's Departments of Orthopaedic Surgery and Radiology found that advanced MRI techniques can be used to detect subtle changes in joint cartilage microstructure and provide physicians a diagnostic tool for finding key markers of early osteoarthritis (OA). By using these techniques during patient exams to identify OA earlier, clinicians can shift the management of the disease from eventual joint reconstruction to long-term preservation. The study was published in the July issue of the Journal of the American Academy of Orthopaedic Surgeons.

"Imaging technology is now sensitive and powerful enough to enable detection of subtle changes in the intricate balance of water, chondrocytes and the collagen fibers and protein molecules that make up our joint cartilage which we now know can point to future osteoarthritis," says Laith Jazrawi, MD, associate professor of orthopaedic surgery and lead author of the paper. "With an active and aging baby boomer population beginning to experience joint pain associated with age, we think there is great potential for bringing these imaging techniques from the lab to the benefit of patients."

The clinical practice standard is to use conventional MRI imaging to assess the quality of cartilage in patients with joint pain, or known arthritis, which focuses on the morphological integrity of the cartilage. In the lab, however, radiologists, orthopedic surgeons, and rheumatologists working as a team have used advances in MRI technology and biochemical imaging techniques to assess cartilage damaged by osteoarthritis. Damaged cartilage shows distinct changes in the concentration of water and collagen molecules, the micro- and macrostructure of collagen, and the concentrations of particular proteins, glycosoaminoglycans. The findings support the use of these MRI techniques in the evaluation of younger patients with joint pain to identify the beginnings of OA allowing for earlier treatment to halt the progression of the disease.

"The development and optimization of these innovative MR techniques has opened up a new window into the understanding and possible treatment of arthritis before irreversible structural and morphological changes has occurred," said Michael P. Recht, MD, Louise Marx professor of radiology and chairman of the Department of Radiology.


Contact: Craig Andrews
NYU Langone Medical Center / New York University School of Medicine

Related biology news :

1. NYU Langone researchers identify a signaling pathway as possible target for cancer treatment
2. NYU Langone Medical Centers tip sheet to the 2011 Alzheimers Association International Conference
3. NYU Langone experts present advances at American Association of Neurological Surgeons Meeting
4. NYU Langone Medical Center receives $5.4 million NYSTEM grant for stem cell research
5. NYU Langone Medical Center awarded NIH grants totaling $1,560,000
6. NYU Langone Medical Center researchers find micro RNA plays a key role in melanoma metastasis
7. Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth
8. Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth
9. Time to let science drive Great Lakes policy on Asian carp, experts say
10. Experts to speak about growth of NYC and implications for transportation policy and infrastructure
11. Experts create first legal roadmap to tackle local ocean acidification hotspots
Post Your Comments:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
Breaking Biology Technology: